Total neoadjuvant FOLFIRINOX in patients with resectable locally advanced gastric and gastroesophageal junction cancer: Updated survival results

被引：0
|
作者：
Sedova, M. [1 ]
Batov, M. [1 ]
Kolomeytseva, A. [1 ]
Khomyakov, V. [2 ]
Volchenko, N. [3 ]
Fedenko, A. A. [4 ]
Kaprin, A. [5 ]
机构：
[1] PA Hertsen Moscow Oncol Res Inst, Chemotherapy, Moscow, Russia
[2] PA Hertsen Moscow Oncol Res Inst, Thoracoabdominal Oncosurg, Moscow, Russia
[3] PA Herzen Moscow Res Oncol Inst Mosc, Oncomorphol, Moscow, Russia
[4] PA Hertsen Moscow Oncol Res Inst, Div Med Oncol, Moscow, Russia
[5] PA Herzen Moscow Res Oncol Inst, Minist Hlth Russian Federat, Natl Med Res Radiol Ctr NMRRC, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428P
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [1] Total neoadjuvant chemotherapy with FOLFIRINOX regimen in patients with resectable locally advanced gastric and gastroesophageal junction cancer
    Sedova, M. V.
    Batov, M. A.
    Kolomeytseva, A. A.
    Khomyakov, V. M.
    Volchenko, N. N.
    Fedenko, A. A.
    Kaprin, A. D.
    ANNALS OF ONCOLOGY, 2023, 34 : S881 - S881
  • [2] Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.
    Liu, Ying
    Han, Guangsen
    Li, Hongle
    Zhao, Yuzhou
    Li, Zhi
    Zhuang, Jing
    Wang, Gangcheng
    Li, Baodong
    Wang, Jinbang
    Li, Zhimeng
    Xia, Qingxin
    Zhang, Chengjuan
    Yu, Juan
    Li, Ke
    Xu, Shuning
    Qiao, Lei
    Kuang, Gaizhen
    Li, Danyang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
    Choi, Jin G.
    Nipp, Ryan D.
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Pandharipande, Pari
    Dowling, Emily C.
    Ferrone, Cristina R.
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-Del Castillo, Carlos
    Ryan, David P.
    Kong, Chung Yin
    Hur, Chin
    ONCOLOGIST, 2019, 24 (07): : 945 - 954
  • [4] Neoadjuvant FOLFIRINOX for patients with borderline resectable or locally advanced pancreatic cancer: Results of a decision analysis.
    Choi, Jin
    Nipp, Ryan David
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Kong, Chung Yin
    Pandharipande, Pari
    Dowling, Emily
    Ferrone, Cristina
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-del Castillo, Carlos
    Ryan, David P.
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Liu, Ying
    Han, Guangsen
    Li, Hongle
    Zhao, Yuzhou
    Zhuang, Jing
    Wang, Gangcheng
    Li, Baodong
    Wang, Jinbang
    Li, Zhimeng
    Xia, Qingxin
    Ma, Jie
    Zhang, Chengjuan
    Yu, Juan
    Li, Ke
    Xu, Shuning
    Qiao, Lei
    Kuang, Gaizhen
    Li, Danyang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
    Liu, Xiao
    Ma, Baozhen
    Zhao, Lingdi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] PROGNOSTIC FACTORS FOR PATIENTS WITH BORDERLINE RESECTABLE OR LOCALLY ADVANCED PANCREATIC CANCER RECEIVING NEOADJUVANT FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2019, 156 (06) : S321 - S322
  • [8] Survival Benefit of Neoadjuvant Chemotherapy for Resectable Cancer of the Gastric and Gastroesophageal Junction A Meta-Analysis
    Jiang, Lei
    Yang, Ke-hu
    Guan, Quan-lin
    Chen, Yan
    Zhao, Peng
    Tian, Jin-hui
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (05) : 387 - 394
  • [9] Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
    Choi, Young Hoon
    Lee, Sang Hyub
    You, Min Su
    Shin, Bang Sup
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Kwon, Wooil
    Jang, Jin-Young
    Kim, Sun-Whe
    GUT AND LIVER, 2021, 15 (02) : 315 - 323
  • [10] Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
    Jiang, Haiping
    Yu, Xiongfei
    Li, Ning
    Kong, Mei
    Ma, Zhimin
    Zhou, Donghui
    Wang, Weibin
    Wang, Haohao
    Wang, Haiyong
    He, Kuifeng
    Li, Zhongqi
    Lu, Yimin
    Zhang, Jing
    Zhao, Kui
    Zhang, Yafei
    Xu, Nong
    Li, Ziran
    Liu, Ying
    Wang, Yan
    Wang, Yisen
    Teng, Lisong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
12345